FINT vs BBP
Comparison between FRONTIER ASSET TOTAL INTERNATIONAL EQUITY ETF (FINT, ETF) and VIRTUS BIOTECH ETF (BBP, ETF).
FINT vs BBP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
FINT
$78M
BBP
$78M
Expense Ratio
FINT
0.87%
Winner
BBP
0.34%
Max Drawdown
Winner
FINT
13.64%
BBP
44.32%
Sharpe Ratio
Winner
FINT
1.51
BBP
1.47
5Y Beta
Winner
FINT
0.72
BBP
0.86
P/E Ratio
FINT
N/A
BBP
-33.91
Forward P/E
FINT
N/A
BBP
13.79
5Y EPS CAGR
FINT
N/A
BBP
2.22%
Debt to Equity
FINT
N/A
BBP
36.59%
P/S Ratio
FINT
N/A
BBP
5.30
P/B Ratio
FINT
N/A
BBP
4.03
FINT vs BBP - Holdings Comparison
FINT and BBP have 0 common holdings. Overlap is 0.00%
FINT's top 25 holdings weight is 99.75%. BBP's top 25 holdings weight is 55.07%.
| Rank | FINT | BBP |
|---|---|---|
| #1 | AVANTIS EMERGING MARKETS EQUITY ETF (AVEM) - 23.06% | IMMUNITYBIO INC ORDINARY SHARES (IBRX) - 5.10% |
| #2 | ISHARES MSCI INTL QUALITY FACTOR ETF (IQLT) - 15.06% | IOVANCE BIOTHERAPEUTICS INC (IOVA) - 3.11% |
| #3 | ISHARES INTERNATIONAL EQUITY FACTOR ETF (INTF) - 14.85% | LEGEND BIOTECH CORP ADR (LEGN) - 2.71% |
| #4 | ISHARES EM MKTS EQ FAC ETF (EMGF) - 11.54% | KALVISTA PHARMACEUTICALS INC (KALV) - 2.65% |
| #5 | VANGUARD INTL DIV APPREC ETF (VIGI) - 9.94% | NOVAVAX INC (NVAX) - 2.59% |
| #6 | FIRST EAGLE OVERSEAS EQUITY ETF (FEOE) - 9.82% | MODERNA INC (MRNA) - 2.58% |
| #7 | CAMBRIA FOREIGN SHAREHOLDER YIELD ETF (FYLD) - 8.62% | AXSOME THERAPEUTICS INC (AXSM) - 2.50% |
| #8 | FRANKLIN INTL LOW VOLATILITY HI DIV ETF (LVHI) - 6.86% | MIRUM PHARMACEUTICALS INC (MIRM) - 2.36% |
| #9 | N/A | ROIVANT SCIENCES LTD ORDINARY SHARES (ROIV) - 2.13% |
| #10 | N/A | TRAVERE THERAPEUTICS INC ORDINARY SHARES (TVTX) - 2.06% |
| #11 | N/A | LIGAND PHARMACEUTICALS INC (LGND) - 2.05% |
| #12 | N/A | KRYSTAL BIOTECH INC (KRYS) - 2.00% |
| #13 | N/A | EXELIXIS INC (EXEL) - 1.98% |
| #14 | N/A | TG THERAPEUTICS INC (TGTX) - 1.95% |
| #15 | N/A | n/a (KNSA) - 1.88% |
| #16 | N/A | BIOCRYST PHARMACEUTICALS INC (BCRX) - 1.84% |
| #17 | N/A | UNITED THERAPEUTICS CORP (UTHR) - 1.82% |
| #18 | N/A | BIOGEN INC (BIIB) - 1.81% |
| #19 | N/A | HALOZYME THERAPEUTICS INC (HALO) - 1.78% |
| #20 | N/A | GILEAD SCIENCES INC (GILD) - 1.77% |
| #21 | N/A | AMGEN INC (AMGN) - 1.72% |
| #22 | N/A | NEUROCRINE BIOSCIENCES INC (NBIX) - 1.69% |
| #23 | N/A | ARROWHEAD PHARMACEUTICALS INC (ARWR) - 1.68% |
| #24 | N/A | BIOMARIN PHARMACEUTICAL INC (BMRN) - 1.67% |
| #25 | N/A | ASCENDIS PHARMA AS (ASND) - 1.64% |
| Total Holdings | 8 | 61 |
FINT vs BBP - Historical Returns
Returns include dividend reinvestment.
1M
Winner
FINT
-1.51%
BBP
-4.70%
3M
Winner
FINT
+6.24%
BBP
-1.59%
6M
Winner
FINT
+14.52%
BBP
+7.53%
1Y
FINT
+26.55%
Winner
BBP
+39.07%
5Y(CAGR)
FINT
N/A
BBP
+9.56%
10Y(CAGR)
FINT
N/A
BBP
+11.61%
Max(CAGR)
Winner
FINT
+28.76%
BBP
+10.90%
FINT vs BBP - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | FINT | BBP |
|---|---|---|
| 2026 | +10.83% | +5.54% |
| 2025 | +29.17% | +31.60% |
| 2024 | -0.15% | +1.76% |
| 2023 | N/A | +19.51% |
| 2022 | N/A | -0.92% |
| 2021 | N/A | -8.54% |
| 2020 | N/A | +23.26% |
| 2019 | N/A | +23.60% |
| 2018 | N/A | -15.04% |
| 2017 | N/A | +24.38% |
| 2016 | N/A | +10.01% |
| 2015 | N/A | +17.91% |
| 2014 | N/A | +0.27% |
FINT vs BBP Drawdown Comparison
The maximum drawdown for FINT was -13.64%, occurring on Apr 8, 2025. Recovery took 31 trading sessions.
The maximum drawdown for BBP was -44.32%, occurring on May 9, 2022. Recovery took 767 trading sessions.
The current FINT drawdown is -3.24%. The current BBP drawdown is -6.96%.
| Rank | FINT | BBP |
|---|---|---|
| #1 | -13.64% Mar 19, 2025 - May 2, 2025 | -44.32% Feb 8, 2021 - Feb 27, 2024 |
| #2 | -10.08% Feb 25, 2026 - May 6, 2026 | -40.50% Jul 20, 2015 - Feb 9, 2017 |
| #3 | -4.24% Jun 2, 2026 - Jun 5, 2026 | -32.25% Jul 13, 2018 - May 11, 2020 |
| #4 | -4.13% Nov 12, 2025 - Dec 10, 2025 | -26.09% Nov 8, 2024 - Sep 2, 2025 |
| #5 | -3.94% Jul 23, 2025 - Aug 13, 2025 | -19.84% Feb 27, 2024 - Jul 15, 2024 |
| #6 | -3.60% Oct 6, 2025 - Oct 24, 2025 | -12.40% Jan 29, 2018 - Jun 19, 2018 |
| #7 | -3.59% Dec 23, 2024 - Jan 23, 2025 | -11.75% Jul 20, 2020 - Oct 7, 2020 |
| #8 | -2.49% May 11, 2026 - May 26, 2026 | -11.54% Apr 23, 2015 - Jun 5, 2015 |
| #9 | -2.36% Jun 12, 2025 - Jun 27, 2025 | -10.58% Jul 16, 2024 - Nov 6, 2024 |
| #10 | -2.34% Feb 20, 2025 - Mar 5, 2025 | -10.39% Oct 5, 2017 - Jan 22, 2018 |
| #11 | -2.19% Oct 27, 2025 - Nov 11, 2025 | -10.09% Jul 24, 2017 - Sep 29, 2017 |
| #12 | -2.08% Mar 7, 2025 - Mar 17, 2025 | -9.28% Feb 24, 2026 - Apr 14, 2026 |
| #13 | -1.91% Aug 22, 2025 - Sep 8, 2025 | -8.86% Mar 3, 2017 - Jun 20, 2017 |
| #14 | -1.82% Jan 30, 2025 - Feb 10, 2025 | -7.56% May 6, 2026 - Jun 2, 2026 |
| #15 | -1.62% Dec 11, 2025 - Dec 22, 2025 | -7.56% Jun 23, 2015 - Jul 14, 2015 |
Correlation
Correlation between FINT and BBP is 0.93 which considered as a very strong positive correlation - the stocks move almost identically together.
0.93
-101
Dividend Comparison (2015 - 2025)
FINT vs BBP dividend yield comparison.
| Year | FINT | BBP |
|---|---|---|
| 2025 | 2.20% | 0.00% |
| 2017 | 0.00% | 0.18% |
| 2015 | 0.00% | 1.29% |
Select Stocks to Compare
Popular: FINT vs SPYBBP vs SPY
More Comparisons
Compare with similar stocks